Skip to main content

Table 1 Main visual acuity, central foveal thickness and high of subretinal fluid in classified eyes CSC eyes

From: Efficacy of nanosecond laser treatment in central serous chorioretinopathy with and without atrophy of retinal pigment epithelium

 Group 1Group 2Group 3
Visual acuity (log MAR)
 Baseline0.18 ± 0.17 (-)0.23 ± 0.19 (-)0.36 ± 0.34 (-)
 1 month0.17 ± 0.19 (0.90)0.22 ± 0.16 (0.86)0.35 ± 0.34 (0.93)
 3 month0.09 ± 0.18 (0.14)0.20 ± 0.24 (0.70)0.32 ± 0.32 (0.72)
 6 month0.11 ± 0.16 (0.30)0.14 ± 0.13 (0.21)0.40 ± 0.24 (0.80)
 2 month0.09 ± 0.14 (0.03)0.16 ± 0.15 (0.11)0.39 ± 0.35 (0.65)
Central foveal thickness (µm)
 Baseline438 ± 189 (-)366 ± 101 (-)338 ± 147 (-)
 1 month280 ± 81 (< 0.01)288 ± 55 (< 0.01)286 ± 92 (0.18)
 3 month265 ± 59 (< 0.01)269 ± 60 (< 0.01)305 ± 106 (0.42)
 6 month280 ± 87 (< 0.01)251 ± 63 (< 0.01)297 ± 97 (0.32)
 12 month245 ± 31 (< 0.01)253 ± 59 (< 0.01)286 ± 80 (0.11)
Subretinal fluid (µm)
 Baseline208 ± 198 (-)140 ± 84 (-)139 ± 130 (-)
 1 month48 ± 81 (< 0.01)53 ± 51 (< 0.01)91 ± 80 (0.01)
 3 month21 ± 50 (< 0.01)34 ± 46 (< 0.01)102 ± 96 (0.01)
 6 month38 ± 89 (< 0.01)19 ± 49 (< 0.01)82 ± 98 (< 0.01)
 12 month0 ± 0 (< 0.01)18 ± 44 (< 0.01)60 ± 74 (< 0.01)